This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Wild, Robert
| Item Type | Name |
|
Concept
|
Estrogen Antagonists
|
|
Concept
|
Estrogens, Conjugated (USP)
|
|
Concept
|
Estrogens
|
|
Concept
|
Receptors, Estrogen
|
|
Concept
|
Selective Estrogen Receptor Modulators
|
|
Concept
|
Estrogen Replacement Therapy
|
|
Academic Article
|
The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study.
|
|
Academic Article
|
Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
|
|
Academic Article
|
Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion.
|
|
Academic Article
|
The need for evidence-based medicine to be integrated into clinical practice: role of the North American Menopause Society.
|
|
Academic Article
|
Insights from the Women's Health Initiative: individualizing risk assessment for hormone therapy decisions.
|
|
Academic Article
|
The gynecologist and the prevention of cardiovascular disease.
|
|
Academic Article
|
The gynecologist and cardiovascular disease: a window of opportunity for prevention.
|
|
Academic Article
|
Estrogens, progestins, selective estrogen receptor modulators, and the arterial tree.
|
|
Academic Article
|
Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.
|
|
Academic Article
|
Role of endogenous estrogen in the hirsutism paradigm.
|
|
Academic Article
|
Hormone replacement: effects on atherogenesis.
|
|
Academic Article
|
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
|
|
Academic Article
|
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.
|
|
Academic Article
|
Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
|
|
Academic Article
|
Coronary artery calcification and osteoporosis: is estrogen an important link?
|
|
Academic Article
|
Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
|
|
Academic Article
|
Risk factors: assessment and preventive measures.
|
|
Academic Article
|
Options for hormone therapy in women who have had a hysterectomy.
|
|
Academic Article
|
Estrogen: effects on the cardiovascular tree.
|
|
Academic Article
|
Metabolic aspects of polycystic ovary syndrome.
|
|
Academic Article
|
Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative.
|
|
Academic Article
|
Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS).
|
|
Academic Article
|
Analgesic Use and Circulating Estrogens, Androgens, and Their Metabolites in the Women's Health Initiative Observational Study.
|
|
Academic Article
|
The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials.
|